Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes

Diabetologia

Volumn 48, Issue 10, 2005, Pages 2013-2017

  Zeggini, E ^a,b   Groves, C J ^a   Parkinson, J R C ^c   Halford, S ^c   Owen, K R ^d   Frayling, T M ^d   Walker, M ^e   Hitman, G A ^f   Levy, J C ^a   O'Rahilly, S ^g   Hattersley, A T ^d   McCarthy, M I ^a,b,c  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d PENINSULA MEDICAL SCHOOL   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Association; Linkage disequilibrium; Lymphotoxin ; TNF; Tumour necrosis factor

Indexed keywords

ARTICLE; CASE CONTROL STUDY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL ANALYSIS;

ADULT; AGE OF ONSET; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 26244448474     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1902-4     Document Type: Article

References (27)

1. McCarthy MI (2004) Progress in defining the molecular basis of type 2 diabetes through susceptibility gene identification. Hum Mol Genet 13(Suppl 1):R33-R41
2. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7
3. Knight JC, Kwiatkowski D (1999) Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 111:290-298
4. Simmonds MJ, Heward JM, Howson JM et al (2004) A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease. Genes Immun 5:267-273
5. Ioannidis JPA, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis JG (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet 361:567-571
6. Nicaud V, Raoux S, Poirier O, Cambien F, O'Reilly DS, Tiret L (2002) The TNF alpha/G -308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II. Atherosclerosis 161:317-325
7. Heijmans BT, Westendorp RG, Droog S, Kluft C, Knook DL, Slagboom PE (2002) Association of the tumour necrosis factor alpha -308G/A polymorphism with the risk of diabetes in an elderly population-based cohort. Genes Immun 3:225-228
8. Li H, Groop L, Nilsson A, Weng J, Tuomi T (2003) A combination of human leukocyte antigen DQB1z.ast;02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes. J Clin Endocrinol Metab 88:2767-2774
9. Kubaszek A, Pihlajamaki J, Komarovski V et al (2003) Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52:1872-1876
10. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M (1998) Tumour necrosis factor alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41:430-434
11. Valenti L, Fracanzani AL, Dongiovanni P et al (2002) Tumour necrosis factor alpha polymorphism and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122:274-280
12. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP (2003) In vivo characterisation of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33:469-475
13. Ozaki K, Ohnishi Y, Iida A et al (2002) Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650-654
14. Hamid YH, Urhammer SA, Glumer C et al (2005) The common T60N polymorphism of the lymphotoxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome. Diabetologia 48:445-451
15. Yamada A, Ichihara S, Murase Y et al (2004) Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med 82:477-483
16. Wiltshire S, Hattersley AT, Hitman GA et al (2001) A genome-wide scan for loci predisposing to type 2 diabetes in a UK population (The Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69:553-569
17. Frayling TM, Walker M, McCarthy MI et al (1999) Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes 48:2475-2479
18. Minton J, Hattersley AT, Owen KR et al (2002) Association studies of genetic variation in the WFS1 gene and type 2 diabetes in UK populations. Diabetes 51:1287-1290
19. Bengra C, Mifflin TE, Khripin Y et al (2002) Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem 48:2131-2140
20. Ye S, Dhillon S, Ke X, Collins AR, Day IN (2001) An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29:E88
21. Zaykin DV, Westfall PH, Young SS, Kamoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79-91
22. Risch N, Teng J (1998) The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I DNA pooling. Genome Res 8:1273-1288
23. McCarthy MI, Whittaker JC (2003) Strategies for positional cloning within regions of established linkage: case selection using IBD status on power of case-control studies. Am J Hum Genet 74(Suppl):2608 [abstract]
24. Ozaki K, Inoue K, Sato H et al (2004) Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 429:72-75
25. Hosszufalusi N, Vatay A, Rajczy K et al (2003) Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 26:452-457
26. Davis TM, Wright AD, Mehta ZM et al (2005) Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia 48:695-702
27. Allcock RJ, Windsor L, Gut IG et al (2004) High-Density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging. Human Mutat 24:517-525